Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 3/20 | 0.35 |
| ▸ | DRD1 | P21728 | 3/20 | 0.35 |
| ▸ | DRD5 | P21918 | 3/20 | 0.35 |
| ▸ | DRD3 | P35462 | 2/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3159469 | 0.86 | DRD2 (0.33) | DRD2DRD1DRD5DRD3DRD4 | |
| SCHEMBL8089987 | 0.82 | DRD2 (0.32) | DRD2DRD1DRD5DRD3 | |
| SCHEMBL8078647 | 0.80 | DRD2 (0.32) | DRD2DRD1DRD5DRD3 | |
| SCHEMBL3160065 | 0.78 | DRD2 (0.33) | DRD2DRD1DRD5 | |
| SCHEMBL1615172 | 0.77 | DRD2 (0.35) | DRD2DRD1DRD5DRD3DRD4 | |
| SCHEMBL1614823 | 0.77 | MAPT (0.31) | MAPT | |
| SCHEMBL5218967 | 0.76 | DRD2 (0.35) | DRD2DRD1DRD5DRD3 | |
| SCHEMBL8086621 | 0.75 | — | — | |
| SCHEMBL8091818 | 0.74 | — | — | |
| SCHEMBL1041155 | 0.74 | DRD1 (0.35) | DRD2DRD1DRD5DRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1538149-B1 | Sulfonium salts as photoinitiators | HENKEL AG & CO KGAA (DE) | 2010-03-17 | — | — | EP | disclosed |
| EP-2112146-A1 | Sulfonium salt photoinitiators and their use | Henkel AG & Co. KGaA (DE) | 2009-10-28 | — | — | EP | disclosed |
| EP-2112147-A1 | Sulfonium salts as photoinitiators | Henkel AG & Co. KGaA (DE) | 2009-10-28 | — | — | EP | disclosed |
| US-7560219-B2 | Arylsulfonium salts of 1-halothioxanthones and 2-decyl-1-tetradecyl bromide as an intermediate for their preparation; UV curable adhesives, sealants, coating compositions, such as printing inks and varnishes, and encapsulants | HENKEL AG & CO. KGAA (DE) | 2009-07-14 | — | — | US | disclosed |
| US-20070203254-A1 | Arylsulfonium salts of 1-halothioxanthones and 2-decyl-1-tetradecyl bromide as an intermediate for their preparation; UV curable adhesives, sealants, coating compositions, such as printing inks and varnishes, and encapsulants | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2007-08-30 | — | — | US | disclosed |
| US-7230122-B2 | Arylsulfonium salts of 1-halothioxanthones and 2-decyl-1-tetradecyl bromide as an intermediate for their preparation; photocurable adhesive, coating or sealant compositions | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2007-06-12 | — | — | US | disclosed |
| EP-1538149-A2 | Sulfonium salts as photoinitiators | National Starch and Chemical Investment Holding Corporation (US) | 2005-06-08 | — | — | EP | disclosed |
| US-20050095531-A1 | Benzophenones substituted with one or more diarylsulfonium groups, used in photocurable adhesive, coating or sealant compositions, especially photocurable hot melt adhesives and a varnishs | HENKEL AG & CO. KGAA (DE) | 2005-05-05 | — | — | US | disclosed |
| US-20050095528-A1 | Arylsulfonium salts of 1-halothioxanthones and 2-decyl-1-tetradecyl bromide as an intermediate for their preparation; photocurable adhesive, coating or sealant compositions | DISPLAY SOURCE ALLIANCE, LLC | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203254-A1 | Arylsulfonium salts of 1-halothioxanthones and 2-decyl-1-tetradecyl bromide as an intermediate for their preparation; UV curable adhesives, sealants, coating compositions, such as printing inks and varnishes, and encapsulants | VCL, DACH1, WDR77 | DRD2 900/4885DRD1 1021/4885DRD5 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.